New York Eye and Ear Infirmary
Adjust: Text Size Make Font Smaller Make Font Larger Print this Page: Normal Print Friendly Large Print Friendly Accessibility Info

Copaxone Dry AMD Therapy Trial

Study Title

Weekly Vaccination with Copaxone as a Potential Therapy for Dry Age Related Macular Degeneration

Enrollment Status

This study is currently recruiting participants.


The purpose of this study is to evaluate how tolerable, safe, and effective it is to give Copaxone subcutaneous injections to adults with dry age related macular degeneration (Dry AMD).


Ages Eligible for Study: 50 years old and older

Genders Eligible for Study: Both

Inclusion Criteria

  • Subjects with the diagnosis of dry age related macular degeneration
  • Aged 50 to 75 years.
  • Must have the presence of drusen and no geographic atrophy

Contact Information

Dr. Richard Rosen, Retina Vitreous Specialist
Katy Tai, Research Manager or 212-979-4251


Home > Current Research > Clinical Trials in Ophthalmology > Copaxone Dry AMD Therapy Trial